News
-
-
-
PRESS RELEASE
Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches Action 2026 global employee stock purchase plan involving 75,000 employees in 52 countries. Employees offered discounted shares with free matching shares and limited purchase amount. Eligibility conditions and holding periods apply -
-
-
-
-
PRESS RELEASE
Communiqué de presse : Le venglustat de Sanofi a été accepté pour un examen prioritaire aux États-Unis afin de traiter la maladie de Gaucher de type 3
Sanofi's venglustat granted priority review by FDA for type 3 Gaucher disease treatment. Potential first US therapy for neurological manifestations. Action date set for Nov 25, 2026 -
PRESS RELEASE
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
Sanofi's venglustat granted priority review by FDA for treating type 3 Gaucher disease. Potential first US therapy for neurological manifestations with target action date on November 25, 2026 -
